Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00962403
Other study ID # 2009-P-000717
Secondary ID 08144033
Status Completed
Phase N/A
First received August 13, 2009
Last updated March 19, 2013
Start date August 2009
Est. completion date May 2012

Study information

Verified date March 2013
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The main objective of this preliminary randomized controlled clinical trial is to establish efficacy and feasibility of a yoga-based treatment for PTSD in military veterans as compared to a delayed yoga treatment (waitlist control) group. Secondary objectives are to evaluate PTSD characteristics that may also be improved with the treatment and acceptability and compliance with the treatment.


Description:

Specific Aims:

1. To evaluate the hypothesis that a 10-week yoga-based intervention will reduce PTSD severity to a statistically and clinically significant degree relative to a pretreatment baseline evaluation and to a waitlist control group.

2. To evaluate the hypothesis that PTSD patients will show improvement in regulation of physiological arousal in the autonomic nervous system relative to pretreatment.

3. To evaluate that hypothesis that symptoms associated with PTSD such as depression, anxiety, insomnia and quality of life will also be improved.

4. To evaluate the hypothesis that military veterans with PTSD can be successfully recruited into a yoga intervention study and will find the intervention acceptable and tolerable and will exhibit high compliance.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male and female military veterans and active duty military personnel aged 18 and older

- A DSM IV diagnosis of post-traumatic stress disorder

- Potential subjects on medications are eligible to participate in the study

- Potential subjects who receive ongoing medical or psychological treatment are eligible to participate in this study as long as these treatments do not include more than one hour weekly of relaxation and mind-body based stress reduction strategies (strategies directly related to meditation and yoga)

- Potential subjects are eligible to participate in this study if they have sufficient mental and physical ability to fully participate in the parameters of the study. Subjects must be able to understand and comply with instructions in the group yoga sessions and home practice, complete questionnaires, participate in clinical interviews, and take part in all data collection activities. Subjects with severe mental or physical concerns that may prevent them from understanding and/or complying with the treatment will be excluded. For example, potential subjects confined to wheelchairs will not be eligible, although subjects with artificial limbs who are able to reasonably participate in the intervention may be deemed eligible. These determinations will be made during discussions with potential subjects on a case by case basis during the screening process

Exclusion Criteria:

- Potential subjects are ineligible if pregnant and in their third trimester.

- Potential subjects are ineligible if they are confined to a wheel chair.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Behavioral:
Yoga treatment
The 10-week Kripalu-style yoga treatment will consist of 20 biweekly 90-minute group training/practice sessions. In addition, subjects will also receive CD's and written instructions for the daily 15-minute sessions, which they will use to guide them through the yoga procedures to be done at home.

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital United States Department of Defense

Country where clinical trial is conducted

United States, 

References & Publications (6)

Creamer M, Burgess P, McFarlane AC. Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being. Psychol Med. 2001 Oct;31(7):1237-47. — View Citation

Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. 2006 Mar 1;295(9):1023-32. — View Citation

Morse DR, Cohen L, Furst ML, Martin JS. A physiological evaluation of the yoga concept of respiratory control of autonomic nervous system activity. Int J Psychosom. 1984;31(1):3-19. — View Citation

Seligman MEP. Learned Optimism, 2nd Edition ed. New York, NY: Pocket Books; 1998.

van der Kolk BA, Roth S, Pelcovitz D, Sunday S, Spinazzola J. Disorders of extreme stress: The empirical foundation of a complex adaptation to trauma. J Trauma Stress. 2005 Oct;18(5):389-99. — View Citation

van der Kolk BA. Clinical implications of neuroscience research in PTSD. Ann N Y Acad Sci. 2006 Jul;1071:277-93. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinician Administered PTSD Scale (CAPS) pre-intervention and 10 weeks No
Secondary PTSD Checklist Military Version (PCL-M) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Impact of Events Scale - Revised (IES-R) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary 25-item Resilience Scale (RS) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Twenty-four-hour urinary samples pre-intervention and 3 months post intervention No
Secondary 10-minute segment of a seated 30-minute electrocardiogram recording session pre-intervention and 3 months post intervention No
Secondary Beck Depression Inventory (BDI) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Spielberger State Trait Anxiety Inventory (STAI) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Daily Sleep Wake Diaries during intervention (weeks 1-10) and 3 months post intervention No
Secondary Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Credibility Expectancy Questionnaire (CEQ) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Body-Oriented State Questionnaire (BOSC) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary 5-Facet Mindfulness Questionnaire (FFMQ) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Perceived Stress Scale (PSS) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
Secondary Yoga Follow-up Questionnaire 3 months post intervention No
Secondary PTSD Checklist Civilian Version (PCL-C) pre-intervention, 5 weeks, 10 weeks and 3 months post intervention No
See also
  Status Clinical Trial Phase
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Completed NCT05112003 - Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot N/A
Recruiting NCT04518267 - Anger and Psychotrauma: Data From Military and Civilians
Completed NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Terminated NCT02234687 - A mGlu2/3 Agonist in the Treatment of PTSD Phase 1
Terminated NCT02520726 - PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims Phase 4
Completed NCT01738308 - The Effects of Healing Touch on Post Operative Pediatric Patients N/A
Completed NCT02213900 - Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy Phase 4
Completed NCT01437891 - Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) N/A
Completed NCT01517711 - Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Phase 4
Completed NCT01199107 - Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01998100 - Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01231711 - Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention Phase 1
Completed NCT00680524 - Telephone-based Care for OEF/OIF Veterans With PTSD N/A
Completed NCT00838006 - Psychophysiologic Predictors of Post-deployment Mental Health Outcomes N/A
Completed NCT00348036 - Group Intervention for Interpersonal Trauma N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00127673 - Comparison of Two Treatments for Post-Traumatic Stress Disorder Phase 3
Completed NCT00158262 - Effect of Propranolol on Preventing Posttraumatic Stress Disorder Phase 4